Inhibition of L-DOPA-Induced Increase in Dopamine Content by Hydrochloride in PC12 cells |
Yin, Shou-Yu
(College of Pharmacy, Yanbian University)
Lee, Jae-Joon (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) Kim, Yu-Mi (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) Jin, Chun-Mei (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) Yang, Yoo-Jung (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) Kang, Min-Hee (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) Lee, Myung-Koo (College of Pharmacy, and Research Center for Bioresource and Health, Chungbuk National University) |
1 | Byrd, J.C., Hadjiconstantinou, M., and Cavalla, D. (1986) Epinephrine synthesis in the PC12 pheochromocytoma cell line. Eur. J. Pharmacol. 127, 139-142 DOI PUBMED ScienceOn |
2 | Myers, R.D. (1989) Isoquinolines, beta-carbolines and alcohol drinking: Involvement of opioid and dopaminergic mechanisms. Experientia. 45, 436-443 DOI PUBMED ScienceOn |
3 | Fang, Q. C., Lin, M., Weng, Q., Zhu, C., and Liu, X. (1981) Chemistry of alkaloids of Corydalis--chemical studies on alkaloids of four Corydalis species from Qinghai plateau (China).Yaoxue Xuebao. 16, 798-800 |
4 | Gjedde, A., Leger, G.C., Cumming, P, Yasuhara, Y., Evans, A.C., Guttman, M., and Kuwabara, H. (1993) Striatal L-dopa decarboxylase activity in Parkinson's desease in vivo: implications for the regulation of dopamine synthesis. J. Neurochem. 61, 1538-1541 DOI PUBMED |
5 | Langston, J.W., Ballard, R., Tetrud, J.W., and Irwin, I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219, 979-980 DOI PUBMED |
6 | Melamed, E., Hefti, F., and Wurtman, R.J. (1979) Nonaminergic striatal neurons convert exogenous L-DOPA to dopamine in Parkinsonism. Ann. Neurol. 8, 558-563 |
7 | Kordower, J.H., Goetz, C.G., Freeman, T.B., and Olanow, C.W. (1997) Dopaminergic transplants in patients with Parkinson's disease: Neuroanatomical correlates of clinical recovery. Exp. Neurol. 144, 41-46 DOI ScienceOn |
8 | Deitrich, R. and Erwin, V. (1980) Biogenic amine aldehyde condensation products: Tetrahydroisoquinolines and tryptolines (-carbolines). Ann. Rev. Pharmacol. Toxicol. 20, 55-80 DOI ScienceOn |
9 | Shin, J.S., Yun-Choi, H.S., Kim, E.I., and Lee, M.K. (1999) Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65, 452-455 DOI ScienceOn |
10 | Schallert, T., Jones, T.A., Norton, D. (1992) A clinically relevant unilateral rat model of Parkinsonian akinesia. J. Neural transplant Plast. 3, 332-333 DOI |
11 | Melamed, E. and Hefti, F. (1984) Mechaniam of action of short-and long-term L-DOPA treatment in Parkinsonism: role of the surviving nigrostriatal dopaminergic neurons. Adv. Neurol. 40, 149-157 PUBMED |
12 | Zhu, M.Y. and Juorio, A.V. (1995) Aromatic L-amino acid decarboxylase: biological characterization and functional role Gen. Pharmacol. 26, 681-696 |
13 | Hefti, F, Melamed, E., and Wurtman, R.J. (1981) The site of dopamine formation in rat striatum after L-dopa administration. J. Pharmacol. Exp. Ther. 217, 189-197 PUBMED |
14 | Shin, J.S., Kim, E.I., Kai, M., Kim, H.S., and Lee, M.K. (1998b) Inhibitory effects of coralyne on dopamine content in PC12 cells. Med. Sci. Res. 26, 745-747 |
15 | Gebreyesus, K., Kilbourne, E.J., and Sabban, E.L. (1993) Bradykinin elevates tyrosine hydroxylase and dopamine -hydroxylase mRNA in PC12 cells. Brain Res. 608, 345-348 DOI PUBMED ScienceOn |
16 | Hughes, A.J., Damiel, S.E., Blankson, S., and Lees, A.J. (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50, 140-148 DOI PUBMED ScienceOn |
17 | Chase, T.N., Baronti, F, Fabbrini, G., Heuser, I.J., Juncos, J.L., and Mouradian, M.M. (1989) Rationale for continuous dipaimnomimetic therapy of Parkinson's desease. Neurology. 39, 7-10 PUBMED |
18 | Fabbrini, G., Mouradian, M.M., Juncos, j.L., Schlegel, J., Mohr, E., and Chase, T.N. (1988) Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Prt J. Ann. Neurol. 24, 366-371 DOI ScienceOn |
19 | Neff, N.H. and Hadjiconstantinou, M. (1995) Aromatic L-amino acid decarboxylase modulation and Parkinson's desease. Prog. Brain Res. 106, 91-97 DOI PUBMED |
20 | Stocchi, F, Bonamartini, A., Vacca, L., and Ruggieri, S. (1996) Motor fluctuations in levodopa treatment: Clinical pharmacology. Eur. Neurol. 36, 38-42 DOI ScienceOn |
21 | Thull, U., Kneubuhler, S., Gaillard, P., Carrupt, P.A., Testa, B., Altomare, C., Carotti, A., Jenner, P., and McNaught, KStP. (1995) Inhibition of monoamine oxidase by isoquinoline derivatives. Biochem. Pharmacol. 50. 869-877 DOI ScienceOn |
22 | Lloyd, K. and Hornykiewicz, O. (1970) Parkinson's desease: activity of L-DOPA decarboxylase in descrete brain regions. Science. 170, 1212-1213 DOI PUBMED ScienceOn |
23 | Melamed, E., Hefti, F., and Wurtman, R.J. (1980) Decarboxylation of exogenous L-DOPA in rat striatum after lesions of the dopaminergic nigrostriatal neurons: the role of striatal capillaries Brain Res. 198, 244-248 DOI ScienceOn |
24 | Baroni, A., Benvenuti, F., Fantini, L., Pantaleo, T., and Urbani, F. (1984) human ballistic ann abduction movements: Effects of L-DOPA treatment in Parkinson's disease. Neurology. 34, 868-876 DOI PUBMED |
25 | Chase, T.N., Engber, T.M., and Mouradian, M.M. (1994) Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease. Neurology. 44, S15-S18 PUBMED |
26 | Rommelspacher, H., May, T., and Susilo, R. (1991) -Carbolines and tetrahydroisoquinolines: Detecdon and function in mammals. Planta Med. 57 (Suppl), S85-S92 DOI PUBMED ScienceOn |
27 | Lee, M.K. and Kim, H.S. (1996) Inhibitory effects of protoberberine alkaloids from the root of Coptic japonica on catecholamine biosynthesis in PC12 cell. Planta Med. 62, 31-34 DOI ScienceOn |
28 | Tischler, A.S., Perlman, R.L., Morse, G.M., and Sheard, B.E. (1983) Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell culture. J. Neurochem. 40, 364-370 DOI PUBMED |
29 | Chang, W.Y. and Webster, R.A. (1997) Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurons in normal and 6-hydroxydopamine-lesioned rats. Br. J. Pharmacol. 121, 331-337 DOI ScienceOn |
30 | Kim, S.H., Shin, J.S., Lee, J.J., Yin, S.Y., Kai, M., and Lee, M.K. (2001) Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67, 609-613 DOI ScienceOn |
31 | Shin, J. S., Kim, K.T., and Lee, M.K. (1998a). Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett. 244, 161-164 DOI ScienceOn |
32 | Rogers, M.W. and Chan, C.W.Y. (1988) Motor planning is impaired in Parkinsons desease. Brain Res. 438, 271-276 DOI PUBMED ScienceOn |
33 | Hefti, F., Melamed, E., and Wurtman, R.J. (1980) The decarboxylation of DOPA in the parkinsonian brain: in vivo studies of an animal model. J. Neural Transm. Suppl. 16, 95-101 PUBMED |